Cite
HARVARD Citation
Stirling, E. et al. (n.d.). 206 An immune-competent tumor organoid platform to test novel immune checkpoint combinations targeting the receptor CD47 in triple negative breast cancer. Journal for immunotherapy of cancer. pp. A121-A122. [Online].